Skip to content
2000
Volume 18, Issue 28
  • ISSN: 1568-0266
  • E-ISSN: 1873-4294

Abstract

Histone deacetylases 6 (HDAC6) has emerged as a promising target for the treatment of various human diseases including cancer, neurodegenerative disease and immunology due to its unique structure, substrate and biological functions. HDAC6 is involved in cell motility, cell survival, cell cycle progression, developmental events, prognosis as well as protein degradation and the involvement of HDAC6 in multiple biological processes has gained lots of attention. There is increasing interest in HDAC6 and its selective inhibitors. More than twenty years of synthetic efforts have developed various HDAC6 selective inhibitors with different Cap, linker and ZBG. This review will summarize recent research data regarding HDAC6 and various HDAC6 selective inhibitors.

Loading

Article metrics loading...

/content/journals/ctmc/10.2174/1568026619666181129141822
2018-11-01
2025-07-07
Loading full text...

Full text loading...

/content/journals/ctmc/10.2174/1568026619666181129141822
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test